Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Chaisson

Showing results (51-60 of 241) with videos related to

Pageof 25
Sort By:
Journal of Urban Health : Bulletin of the New York Academy of Medicine|April 9, 2002
Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange programElise D Riley, David Vlahov, Steven Huettner, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|June 8, 2022
Tuberculosis: a deadly and neglected disease in the COVID-19 eraEthel L Maciel, Jonathan E Golub, Jose Roberto Lapa E Silva, et al.
Journal of the International AIDS Society|October 27, 2020
Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIVHyejeong Shin, Youngji Jo, Richard E Chaisson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2008
Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testingDavid W Dowdy, Richard E Chaisson, Gary Maartens, et al.
Infectious Disorders Drug Targets|March 17, 2011
Management of adult active tuberculosis disease in era of HIV pandemic, current practices and future perspectivesJean B Nachega, Bernd Rosenkranz, Gary Simon, et al.
JAMA|July 4, 2002
Hepatitis C and progression of HIV diseaseMark S Sulkowski, Richard D Moore, Shruti H Mehta, et al.
Genes and Immunity|December 20, 2018
The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progressionRia Lassaunière, Maria Paximadis, Osman Ebrahim, et al.
Hepatology (Baltimore, Md.)|January 12, 2002
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infectionsMark S Sulkowski, David L Thomas, Shruti H Mehta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 7, 2003
The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected personsShruti H Mehta, Richard D Moore, David L Thomas, et al.
Clinical Immunology (Orlando, Fla.)|April 22, 2017
CXCR6 gene characterization in two ethnically distinct South African populations and association with viraemic disease control in HIV-1-infected black South African individualsAnabela C P Picton, Maria Paximadis, Richard E Chaisson, et al.
Pageof 25

Showing results (51-60 of 241) with videos related to

Sort By:
Pageof 25
Journal of Urban Health : Bulletin of the New York Academy of Medicine|April 9, 2002
Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange programElise D Riley, David Vlahov, Steven Huettner, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|June 8, 2022
Tuberculosis: a deadly and neglected disease in the COVID-19 eraEthel L Maciel, Jonathan E Golub, Jose Roberto Lapa E Silva, et al.
Journal of the International AIDS Society|October 27, 2020
Cost-effectiveness of a 12 country-intervention to scale up short course TB preventive therapy among people living with HIVHyejeong Shin, Youngji Jo, Richard E Chaisson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2008
Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testingDavid W Dowdy, Richard E Chaisson, Gary Maartens, et al.
Infectious Disorders Drug Targets|March 17, 2011
Management of adult active tuberculosis disease in era of HIV pandemic, current practices and future perspectivesJean B Nachega, Bernd Rosenkranz, Gary Simon, et al.
JAMA|July 4, 2002
Hepatitis C and progression of HIV diseaseMark S Sulkowski, Richard D Moore, Shruti H Mehta, et al.
Genes and Immunity|December 20, 2018
The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progressionRia Lassaunière, Maria Paximadis, Osman Ebrahim, et al.
Hepatology (Baltimore, Md.)|January 12, 2002
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infectionsMark S Sulkowski, David L Thomas, Shruti H Mehta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 7, 2003
The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected personsShruti H Mehta, Richard D Moore, David L Thomas, et al.
Clinical Immunology (Orlando, Fla.)|April 22, 2017
CXCR6 gene characterization in two ethnically distinct South African populations and association with viraemic disease control in HIV-1-infected black South African individualsAnabela C P Picton, Maria Paximadis, Richard E Chaisson, et al.
Pageof 25